MyMD Pharmaceuticals (MYMD) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Ecosystem Environment Environmental Environmental Protection Intensity Materials Natural Resources Nature Offset Package Packaging Pandemic Raw Materials Toxic Waste Water Access Benefits Black California Consumer Privacy Act Collective Bargaining Community Customer Customer Satisfaction Cyber Cyber Security Cybersecurity Data Privacy Data Security Death Disability Diversity Drug Pricing Employee Employee Retention Engagement Ethnicity General Data Protection Regulation Health Care Healthcare Hire Hiring Incident Injuries Injury Opioid Privacy Product Safety Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Society Stakeholder Supplier Supply Chain Training Union Volunteer Workers Activist Assessment Assurance Attorneys General Audit Bonus Chronic Classified Classified Board Clawback Commitment Corporate Governance Corporate Purpose Corruption Department of Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Mission Oversight Plaintiff Pledging Proxy Contest Purpose Recoup Reputation Reputational Research and Development Responsibility Responsible Self-evaluation Special Meeting Strategy Sustainable Targets Tax Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On December 14, 2022, MyMD Pharmaceuticals, Inc. (the “Company”) held its 2022 annual meeting of stockholders (the “Annual Meeting”). At the Company’s Annual Meeting, holders of the Company’s voting securities with a total aggregate voting power of 30,840,727 votes were present in person or represented by proxy. The matters submitted for a vote and the related results are set forth below.

(1)

Election of six (6) directors to hold office for a one year term and until their successors are elected and qualified or until their earlier incapacity, removal or resignation:

Nominee	Votes For	Votes Withheld	Broker Non-Votes
Chris Chapman	19,923,914	287,893	10,628,920
Craig Eagle	20,115,061	96,746	10,628,920
Christopher C. Schreiber	20,066,262	145,545	10,628,920
Joshua Silverman	18,720,289	1,491,518	10,628,920
Jude Uzonwanne	17,816,077	2,395,730	10,628,920
Bill J. White	20,157,803	54,004	10,628,920

The terms of the Company’s directors were scheduled to expire at the Annual Meeting, and the Board nominated all six directors for re-election at the Annual Meeting. At the Annual Meeting, Dr. Chris Chapman, Dr. Craig Eagle, Mr. Christopher C. Schreiber, Mr. Joshua Silverman, Mr. Jude Uzonwanne, and Mr. Bill J. White were elected as directors of the Board to serve for a term expiring at the Company’s 2023 annual meeting of stockholders.

(2)

Ratification of the appointment of Morison Cogen LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022:

Votes For		Votes Against		Votes Abstaining
30,778,525		40,617		21,585

For more information about the foregoing proposals, see the Company’s definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on October 26, 2022, the relevant portions of which are incorporated herein by reference.

The results reported above are final voting results. No other matters were considered or voted upon at the Annual Meeting.